Chitosan oligosaccharides inhibit the expression of interleukin-6 in lipopolysaccharide-induced human umbilical vein endothelial cells through p38 and ERK1/2 protein kinases

Basic and Clinical Pharmacology and Toxicology

Volumn 106, Issue 5, 2010, Pages 362-371

  Liu, Hong Tao ^a,b,c   Li, Wen Ming ^b   Li, Xiu Ying ^b   Xu, Qing Song ^a   Liu, Qi Shun ^a   Bai, Xue Fang ^a   Yu, Chao ^b   Du, Yu Guang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHITOSAN OLIGOSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OLIGOSACCHARIDE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

CHITOSAN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 6; OLIGOSACCHARIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; UMBILICAL VEINS; UP-REGULATION;

EID: 77951043764     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00493.x     Document Type: Article

References (32)

1. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 2005 68 : 26 36. (Pubitemid 41253553)
2. Fasanaro P, Magenta A, Zaccagnini G, Cicchillitti L, Fucile S, Eusebi F et al. Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress. FASEB J 2006 20 : 1242 1244.
3. Schildberg FA, Schulz S, Dombrowski F, Minor T. Cyclic AMP alleviates endoplasmic stress and programmed cell death induced by lipopolysaccharides in human endothelial cells. Cell Tissue Res 2005 320 : 91 8. (Pubitemid 40543765)
4. Yoon HJ, Moon ME, Park HS, Im SY, Kim YH. Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. Biochem Biophys Res Commun 2007 358 : 954 959.
5. Friebe A, Volk HD. Stability of tumor necrosis factor alpha, interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activation. Arch Pathol Lab Med 2008 132 : 1802 1806.
6. Weglarz L, Dzierzewicz Z, Skop B, Orchel A, Parfiniewicz B, Wiśniowska B et al. Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression. Cell Mol Biol Lett 2003 8 : 991 1003. (Pubitemid 38095075)
7. Garbin U, Fratta Pasini A, Stranieri C, Manfro S, Mozzini C, Boccioletti V et al. Effects of nebivolol on endothelial gene expression during oxidative stress in human umbilical vein endothelial cells. Mediators Inflamm 2008 doi :.
8. Isoda K, Young JL, Zirlik A, MacFarlane LA, Tsuboi N, Gerdes N et al. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol 2006 26 : 611 617.
9. Arvanitoyannis IS, Nakayama A, Aiba SI. Chitosan and gelatin based edible films: state diagrams, mechanical and permeation properties. Carbohydr Polym 1998 37 : 371 382.
10. Harish Prashanth KV, Tharanathan RN. Depolymerized products of chitosan as potent inhibitors of tumor-induced angiogenesis. Biochim Biophys Acta 2005 1722 : 22 9.
11. Wu GJ, Tsai GJ. Chitooligosaccharides in combination with interferon-gamma increase nitric oxide production via nuclear factor-kappaB activation in murine RAW264.7 macrophages. Food Chem Toxicol 2007 45 : 250 258.
12. Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev 2001 52 : 105 115. (Pubitemid 33079166)
13. Xu JG, Zhao XM, Han XW, Du YG. Antifungal activity of oligochitosan against Phytophthora capsici and other plant pathogenic fungi in vitro. Pestic Biochem Physiol 2007 87 : 220 228. (Pubitemid 46176040)
14. Moon JS, Kim HK, Koo HC, Joo YS, Nam HM, Park YH et al. The antibacterial and immunostimulative effect of chitosan-oligosaccharides against infection by Staphylococcus aureus isolated from bovine mastitis. Appl Microbiol Biotechnol 2007 75 : 989 998.
15. Lidington EA, Moyes DL, McCormack AM, Rose ML. A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transpl Immunol 1999 7 : 239 246. (Pubitemid 30021354)
16. Zhang H, Du YG, Yu X, Mitsutomi M, Aiba S. Preparation of chitooligosaccharides from chitosan by a complex enzyme. Carbohydr Res 1999 320 : 257 260. (Pubitemid 29488509)
17. Burlacu A, Jinga V, Gafencu AV, Simionescu M. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res 2001 306 : 409 416. (Pubitemid 33139899)
18. Galley HF, Dhillon JK, Paterson RL, Webster NR. Effect of ciprofloxacin on the activation of the transcription factors nuclear factor kappaB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line. Clin Sci (Lond) 2000 99 : 405 410.
19. Ponce C, Torres M, Galleguillos C, Sovino H, Boric MA, Fuentes A et al. Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis. Reproduction 2009 137 : 727 737.
20. Schumann RR, Pfeil D, Lamping N, Kirschning C, Scherzinger G, Schlag P et al. Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. Blood 1996 87 : 2805 2814. (Pubitemid 26102230)
21. Sukovich DA, Kauser K, Shirley FD, DelVecchio V, Halks-Miller M, Rubanyi GM. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol. Arterioscler Thromb Vasc Biol 1998 18 : 1498 1505. (Pubitemid 28421889)
22. Oh GS, Pae HO, Choi BM, Lee HS, Kim IK, Yun YG et al. Penta-O-galloyl-beta-d-glucose inhibits phorbol myristate acetate-induced interleukin-8 gene expression in human monocytic U937 cells through its inactivation of nuclear factor-kappaB. Int Immunopharmacol 2004 4 : 377 386.
23. Talmor Y, Bernheim J, Klein O, Green J, Rashid G. Calcitriol blunts pro-atherosclerotic parameters through NF kappaB and p38 in vitro. Eur J Clin Invest 2008 38 : 548 554. (Pubitemid 352019134)
24. Desai TR, Leeper NJ, Hynes KL, Gewertz BL. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res 2002 104 : 118 123.
25. Rajan S, Ye J, Bai S, Huang F, Guo YL. NF-kappaB, but not p38 MAP kinase, is required for TNF-alpha-induced expression of cell adhesion molecules in endothelial cells. J Cell Biochem 2008 105 : 477 486.
26. Ichiyama T, Ueno Y, Isumi H, Niimi A, Matsubara T, Furukawa S. An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of coronary arteries in vitro. Inflamm Res 2004 53 : 253 256. (Pubitemid 38797562)
27. Nizamutdinova IT, Oh HM, Min YN, Park SH, Lee MJ, Kim JS et al. Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways. Int Immunopharmacol 2007 7 : 343 350.
28. Ying B, Yang T, Song X, Hu X, Fan H, Lu X et al. Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways. Mol Biol Rep 2009 36 : 1825 32
29. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002 298 : 1911 1912. (Pubitemid 35425238)
30. Hippenstiel S, Soeth S, Kellas B, Fuhrmann O, Seybold J, Krüll M et al. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 2000 95 : 3044 3051. (Pubitemid 30321152)
31. Andreozzi F, Laratta E, Procopio C, Hribal ML, Sciacqua A, Perticone M et al. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells. Mol Cell Biol 2007 27 : 2372 2383. (Pubitemid 46418488)
32. Wu WT, Chi KH, Ho FM, Tsao WC, Lin WW. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. Biochem J 2004 379 (Pt 3 587 593.